Hikma Pharmaceuticals has filed a breach-of-contract lawsuit against insurance company Lloyd’s of London, claiming its insurers have failed to honor their product liability insurance and indemnify Hikma as it battles multidistrict litigation relating to its opioid products.
The complaint, filed in Manhattan Supreme Court, alleges that Lloyd’s and its subsidiaries have abandoned Hikma as it battles some 900 opioid-related lawsuits variously alleging its products were defective, dangerous, and caused illness, addiction and death.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
